AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Plasmodium vivax adapted to Aotus monkeys aids malaria vaccine development.

Vaccine Weekly

| November 12, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 NOV 12 - (NewsRx.com & NewsRx.net) -- Discovery of a highly infective Plasmodium vivax strain adapted to Aotus monkeys will aid malaria vaccine development.

According to a study from Colombia, "The New World primate Aotus nancymaae is susceptible to infection by the human malaria parasite Plasmodium vivax and has therefore been recommended by the World Health Organization as a model for malaria vaccine candidate evaluation. We report the isolation, adaptation, titration, and genetic characterization of a R. vivax wild strain in splenectomized A. nancymaae monkeys."

"Parasitemia remained high after 22 passages, reaching 7.88% by Giemsa and Acridine Orange staining and Real-Time PCR determination, making this P. vivax strain a highly infective and reliable asset to be used in R. vivax biological studies and vaccine development," reported Yago Pico de Coana and collaborators at the Fundacion Instituto de Inmunologia de Colombia (FIDIC) and the ...

Related articles from newspapers, magazines, journals, and more
Plasmodium vivax adapted to Aotus monkeys aids malaria vaccine development.
Newspaper article from: Drug Week November 14, 2003 700+ words
...monkeys will aid malaria vaccine development. According to a...useful for P. vivax malaria vaccine development. Vaccine, 2003...subject areas of Malaria Vaccine, Animal Models, Vaccine Development, Mosquito-borne...
Vical and Naval Medical Research Institute awarded Defense Department grant for...
Press release article from: Business Wire September 5, 1995 700+ words
...1 million per year for up to three years to support further development of a malaria vaccine based on Vical's naked DNA vaccine technology. Vaccine development will take place both at Vical and at the Naval Medical Research Institute (NMRI...
DNA Immunization Helps Malaria Vaccine Development.(Brief Article)(Statistical...
Newspaper article from: Vaccine Weekly November 1, 1999 700+ words
...of an effective malaria vaccine strategy, say researchers...making traditional vaccine development more difficult...for developing a malaria vaccine are complicated...DNA-based human malaria vaccine." This article...
United States: Crucell wins funding for malaria vaccine development.
News wire article from: TendersInfo July 30, 2009 700+ words
...accelerate the development of a malaria vaccine as it entered into a collaboration...collaboration with the PATH Malaria Vaccine Initiative (MVI) and the...International Development (USAID) Malaria Vaccine Development Program (MVDP). Via funding...
Public-Private Partnership Leads to Scientific Breakthrough in Malaria Vaccine...
Press release article from: PR Newswire October 14, 2004 700+ words
...Efficacy Clinical Trial of Malaria Vaccine in Africa to be Published...that a Plasmodium falciparum malaria vaccine based on the circumsporozoite...created to overcome barriers to malaria vaccine development. "They provide convincing...
U.S. Congressman Rush Holt Visits VaxInnate to Announce Govt. Funding for...
Press release article from: Business Wire November 30, 2006 700+ words
...clinical research on a malaria vaccine based on the company's...current egg-based method of vaccine development and production is outdated...change the way we approach malaria vaccine development - with the potential to not...
Boost for Malaria Vaccine Development by Combining Strengths of Dutch and...
Press release article from: PR Newswire January 16, 2008 700+ words
...that is aimed at the development of a malaria vaccine. This TI Pharma project will be an...aims to develop a highly protective malaria vaccine that would save the lives of millions...especially infants and children. No malaria vaccine is currently commercially available...
Epimmune Receives Notice of NIH Intention to Fund $2.8 Million for Malaria...
Press release article from: PR Newswire July 13, 2004 700+ words
...preclinical development of a multi-epitope malaria vaccine. The NIH decision follows successful...candidate suitable for human testing. The Malaria Vaccine Challenge According to the NIH, malaria...the need for a broadly effective malaria vaccine is increasing. Efforts to develop...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA